Published in Lab Business Week, May 11th, 2008
The company also announced that its board of directors has authorized a stock repurchase program, authorizing management, at its discretion, to repurchase up to $5 million of the company's outstanding common stock from time to time over the next 12 months through open market or privately negotiated transactions. The amount and timing of specific repurchases are subject to market conditions, applicable legal requirements and other factors. The repurchase program may be modified, extended or terminated by the board of directors at any time,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.